Design of fluorinated cyclopropane derivatives of 2-phenylcyclopropylmethylamine leading to identification of a selective serotonin 2C (5-HT2C) receptor agonist without 5-HT2B agonism

Eur J Med Chem. 2019 Nov 15:182:111626. doi: 10.1016/j.ejmech.2019.111626. Epub 2019 Aug 14.

Abstract

A new series of fluorinated 5-HT2C agonists were designed and synthesized on the basis of our previous work on 2-phenylcyclopropylmethylamines as a potential approach for the treatment of central nervous system disorders. Key fluorinated cyclopropane moieties were constructed through transition metal catalyzed [2 + 1]-cycloaddition of aromatic vinyl fluorides, and the absolute stereochemistry of the representative compound (-)-21a was established. Functional activity measuring calcium flux at 5-HT2 receptors reveals high potency for compounds (+)-21a-d. In particular, (+)-21b had no detectable 5-HT2B agonism and displayed reasonable selectivity against 5-HT2A. Molecular docking studies were further performed to explain the compounds' possible binding poses to the 5-HT2C receptor.

Keywords: 5-HT(2B) receptor; 5-HT(2C) receptor; Agonist; Asymmetric synthesis; Fluorinated cyclopropane.

MeSH terms

  • Cyclopropanes / chemical synthesis
  • Cyclopropanes / chemistry
  • Cyclopropanes / pharmacology*
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Halogenation
  • Humans
  • Methylamines / chemical synthesis
  • Methylamines / chemistry
  • Methylamines / pharmacology*
  • Molecular Docking Simulation
  • Molecular Structure
  • Receptor, Serotonin, 5-HT2B / metabolism
  • Receptor, Serotonin, 5-HT2C / metabolism*
  • Structure-Activity Relationship

Substances

  • Cyclopropanes
  • Methylamines
  • Receptor, Serotonin, 5-HT2B
  • Receptor, Serotonin, 5-HT2C
  • cyclopropane